ArticleIntegrative cancer therapies
Patients' Expectations and Barriers Toward Reishi Mushroom Use in Cancer Care: A Cross-Sectional Survey.
Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundReishi mushroom is one of the most commonly used supplements among cancer patients. However, limited data exists on why patients choose Reishi. This study aimed to explore patients' expectations and barriers to using Reishi.
methodsWe conducted a cross-sectional survey study of a cancer population from Mainland China who reported using Reishi. Participants were recruited using a customer database from Zhongke Health International LLC. Patients' expectations and barriers to Reishi use were assessed using a modified version of the Attitudes and Beliefs Toward Complementary and Alternative Medicine (ABCAM) survey. Multivariable linear regression models were applied to examine whether socio-demographic and clinical factors, as well as Reishi usage patterns, influenced participants' attitudes toward Reishi.
resultsAmong 1374 participants, the most common sources of information about Reishi products were friends (49.78%) and family (36.83%). More than half (55.9%) used additional traditional Chinese herbal remedies in combination with Reishi. The most frequently cited expectations for Reishi use were boosting immunity (45% strongly agreed) and improving physical health (41% strongly agreed). 72% identified cost and insurance coverage as the primary barriers to Reishi usage. Approximately 10% considered side effects and limited research evidence as barriers. Stage IV cancer and duration of Reishi use >5 years were significantly associated with higher expectations and lower perceived barriers.
conclusionThis study identified the most common expectations and barriers to Reishi use in cancer care in Mainland China. These findings can help clinicians better understand patient perspectives and integrate herbal supplements more effectively into supportive cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.